Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus

被引:35
作者
Mendoza-Pinto, Claudia [2 ]
Garcia-Carrasco, Mario [2 ,3 ]
Sandoval-Cruz, Hilda [4 ]
Escarcega, Ricardo O. [5 ]
Jimenez-Hernandez, Mario [2 ,6 ]
Etchegaray-Morales, Ivet [2 ]
Soto-Vega, Elena [2 ]
Munoz-Guarneros, Margarita [2 ]
Lopez-Colombo, Aurelio [7 ]
Deleze-Hinojosa, Margarita [8 ]
Cervera, Ricard [1 ,6 ]
机构
[1] Hosp Clin Barcelona, Servei Malalties Autoimmunes, E-08036 Barcelona, Catalonia, Spain
[2] Inst Mexicano Seguro Social, Syst Autoimmune Dis Res Unit, HGR 36, CMN Manuel Avila Camacho, Puebla, Mexico
[3] Univ Autonoma Puebla, Dept Rheumatol, Med Sch Benemeriat, Puebla 72570, Mexico
[4] Inst Mexicano Seguro Social, Radiol Unit, HGR 36, CMN Manuel Avila Camacho, Puebla, Mexico
[5] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA
[6] Hosp Clin Barcelona, Dept Autoimmune Dis, Inst Clin Med & Dermatol, E-08036 Barcelona, Catalonia, Spain
[7] Inst Mexicano Seguro Social, State Res Dept, Puebla, Mexico
[8] Childrens Hosp Los Angeles, Osteoporosis Clin, Puebla, Mexico
关键词
Bone mineral density; Osteoporosis; Pre-menopausal; Systemic lupus erythematosus; REVISED CRITERIA; DISEASE-ACTIVITY; FEMALE-PATIENTS; HORMONAL STATUS; OSTEOPOROSIS; PREVALENCE; MASS; CLASSIFICATION; VALIDATION; PREDICTORS;
D O I
10.1007/s10067-008-0984-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the prevalence and risk factors for low bone mineral density (BMD) in women with systemic lupus erythematosus (SLE). A cross-sectional study was conducted among 100 pre-menopausal patients with SLE. Patients were evaluated using a questionnaire about the following variables: age, disease duration, disease activity, chronic disease damage, cumulative corticosteroid dose, and history of fracture. Lumbar spine and hip measurements of BMD were performed by dual absorptiometry. Univariate and multivariate statistical analyses were used to assess the relationship between risk factors and BMD. The mean age was 32.8 +/- 8.7 years, and the median duration of SLE was 73.2 +/- 65 months. The mean cumulative corticosteroid dose was 20.0 +/- 21.3 g. The mean BMD was 1.09 +/- .18 g/cm(2) in the lumbar spine and 1.0 +/- .14 g/cm(2) in the hip. Osteopenia was present in 40% of patients and osteoporosis in 5%. In the multiple regression analysis, low BMD in the lumbar spine was associated with chronic disease damage and low body mass index (BMI). Low BMD in the hip was associated with cumulative corticosteroid dose and low BMI. Chronic disease damage, low BMI, and cumulative corticosteroid dose are risks factors for low BMD in pre-menopausal SLE patients. Osteopenia was found in 40% of patients, while osteoporosis was found in only 5%.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 45 条
[1]   Prevalence and risk factors of osteoporosis in female SLE patients - extended report [J].
Almehed, K. ;
d'Elia, H. Forsbad ;
Kvisti, G. ;
Ohlsson, C. ;
Carlsten, H. .
RHEUMATOLOGY, 2007, 46 (07) :1185-1190
[2]   Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage [J].
Becker, A ;
Fischer, R ;
Scherbaum, WA ;
Schneider, M .
LUPUS, 2001, 10 (11) :809-814
[3]   Bone mineral density in women with systemic lupus erythematosus [J].
Bhattoa, HP ;
Bettembuk, P ;
Balogh, A ;
Szegedi, G ;
Kiss, E .
CLINICAL RHEUMATOLOGY, 2002, 21 (02) :135-141
[4]   Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus [J].
Bhattoa, HP ;
Kiss, E ;
Bettembuk, P ;
Balogh, A .
RHEUMATOLOGY INTERNATIONAL, 2001, 21 (03) :97-102
[5]   Bone mineral density changes in women with systemic lupus erythematosus [J].
Boyanov, M ;
Robeva, R ;
Popivanov, P .
CLINICAL RHEUMATOLOGY, 2003, 22 (4-5) :318-323
[6]   Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus [J].
Bultink, IEM ;
Lems, WF ;
Kostense, PJ ;
Dijkmans, BAC ;
Voskuyl, AE .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :2044-2050
[7]   Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients [J].
Cervera, R ;
Khamashta, MA ;
Font, J ;
Sebastiani, GD ;
Gil, A ;
Lavilla, P ;
Mejía, JC ;
Aydintug, AC ;
Chwalinska-Sadowska, H ;
de Ramón, E ;
Fernández-Nebro, A ;
Galeazzi, M ;
Valen, M ;
Mathieu, A ;
Houssiau, FD ;
Caro, N ;
Alba, P ;
Ramos-Casals, M ;
Ingelmo, M ;
Hughes, GRV .
MEDICINE, 2003, 82 (05) :299-308
[8]   Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy [J].
Coimbra, IB ;
Costallat, LTL .
JOINT BONE SPINE, 2003, 70 (01) :40-45
[9]   POPULATION-BASED STUDY OF SURVIVAL AFTER OSTEOPOROTIC FRACTURES [J].
COOPER, C ;
ATKINSON, EJ ;
JACOBSEN, SJ ;
OFALLON, WM ;
MELTON, LJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) :1001-1005
[10]   SLE: challenges and candidates in human disease [J].
Croker, JA ;
Kimberly, RP .
TRENDS IN IMMUNOLOGY, 2005, 26 (11) :580-586